Top Midday Decliners

MT Newswires Live09-05

Athira Pharma (ATHA) shares plunged 78% after the company said overnight that its phase 2/3 trial of fosgonimeton in people with mild-to-moderate Alzheimer's disease failed to meet the primary and key secondary endpoints.

More than 14.6 million shares traded intraday compared with a daily average of about 172,000.

Oragenics (OGEN) said Wednesday that it priced a public offering of about 8.11 million shares at $0.55 apiece for gross proceeds of about $4.45 million. The stock closed at $1.07 Tuesday.

Shares slumped 44%, with intraday trading volume at over 2.43 million compared with a daily average of about 601,000.

Dollar Tree (DLTR) reported lower-than-expected Q2 results and reduced its outlook for the full financial year.

Shares dropped 24% as intraday trading volume rose to over 22 million from a daily average of about 2.95 million.

Price: 0.63, Change: -2.21, Percent Change: -77.92

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2465107582?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-09-05 02:29","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2465107582","market":"hk","top_or_hot":-1,"title":"Top Midday Decliners","media":"MT Newswires Live","content":"<html><body><p> Athira Pharma (ATHA) shares plunged 78% after the company said overnight that its phase 2/3 trial of fosgonimeton in people with mild-to-moderate Alzheimer's disease failed to meet the primary and key secondary endpoints.</p><p>More than 14.6 million shares traded intraday compared with a daily average of about 172,000.</p><p>Oragenics (OGEN) said Wednesday that it priced a public offering of about 8.11 million shares at $0.55 apiece for gross proceeds of about $4.45 million. The stock closed at $1.07 Tuesday.</p><p>Shares slumped 44%, with intraday trading volume at over 2.43 million compared with a daily average of about 601,000.</p><p>Dollar Tree (DLTR) reported lower-than-expected Q2 results and reduced its outlook for the full financial year.</p><p>Shares dropped 24% as intraday trading volume rose to over 22 million from a daily average of about 2.95 million.</p><p>Price: 0.63, Change: -2.21, Percent Change: -77.92</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Top Midday Decliners</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTop Midday Decliners\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-09-05 02:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.mtnewswires.com/><strong>MT Newswires Live</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Athira Pharma (ATHA) shares plunged 78% after the company said overnight that its phase 2/3 trial of fosgonimeton in people with mild-to-moderate Alzheimer's disease failed to meet the primary and key...</p>\n\n<a href=\"https://www.mtnewswires.com/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4585","symbol_name":"ETF&股票定投概念","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2465107582","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2465107582","pubTimestamp":1725474598,"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Athira Pharma  shares plunged 78% after the company said overnight that its phase 2/3 trial of fosgonimeton in people with mild-to-moderate Alzheimer's disease failed to meet the primary and key secondary endpoints.More than 14.6 million shares traded intraday compared with a daily average of about 172,000.Oragenics  said Wednesday that it priced a public offering of about 8.11 million shares at $0.55 apiece for gross proceeds of about $4.45 million. The stock closed at $1.07 Tuesday.Shares slumped 44%, with intraday trading volume at over 2.43 million compared with a daily average of about 601,000.Dollar Tree  reported lower-than-expected Q2 results and reduced its outlook for the full financial year.Shares dropped 24% as intraday trading volume rose to over 22 million from a daily average of about 2.95 million.Price: 0.63, Change: -2.21, Percent Change: -77.92","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4585":"ETF&股票定投概念","DLTR":"美元树公司","BK4155":"大卖场与超市","BK4139":"生物科技","BK4588":"碎股","BK4504":"桥水持仓","BK4007":"制药","OGEN":"Oragenics Inc.","BK4114":"综合货品商店","LU0006061336.USD":"Blackrock US Small and MidCap Opportunities A2 USD","ATHA":"Athira Pharma, Inc."},"translate_title":"午盘跌幅最大的股票","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ATHA":0.9,"DLTR":0.9,"OGEN":0.9},"content_text":"Athira Pharma (ATHA) shares plunged 78% after the company said overnight that its phase 2/3 trial of fosgonimeton in people with mild-to-moderate Alzheimer's disease failed to meet the primary and key secondary endpoints.More than 14.6 million shares traded intraday compared with a daily average of about 172,000.Oragenics (OGEN) said Wednesday that it priced a public offering of about 8.11 million shares at $0.55 apiece for gross proceeds of about $4.45 million. The stock closed at $1.07 Tuesday.Shares slumped 44%, with intraday trading volume at over 2.43 million compared with a daily average of about 601,000.Dollar Tree (DLTR) reported lower-than-expected Q2 results and reduced its outlook for the full financial year.Shares dropped 24% as intraday trading volume rose to over 22 million from a daily average of about 2.95 million.Price: 0.63, Change: -2.21, Percent Change: -77.92","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2465107582"}